CBD shows potential against stomach and colorectal cancers through multiple pathways
A systematic review found CBD targets gastrointestinal cancers through apoptosis, cell cycle regulation, anti-angiogenesis, and inflammation reduction, with potential to enhance conventional therapies and overcome treatment resistance.
Quick Facts
What This Study Found
CBD modulated multiple molecular pathways relevant to GI cancers, including inducing apoptosis and cell cycle arrest, inhibiting new blood vessel formation, reducing inflammation, and potentially enhancing chemotherapy effectiveness and overcoming drug resistance.
Key Numbers
CBD mechanisms in GI cancers included: apoptosis induction, cell cycle arrest, angiogenesis inhibition, inflammation reduction, and chemosensitization. Focus on gastric and colorectal cancer models.
How They Did This
Systematic review examining preclinical and early clinical evidence on CBD in gastric and colorectal cancers, analyzing molecular pathways and therapeutic potential.
Why This Research Matters
Gastrointestinal cancers are among the most common and deadly cancers globally. CBD's multi-target approach and potential to overcome treatment resistance address key challenges in GI oncology.
The Bigger Picture
Colorectal cancer treatment has improved but resistance remains a major hurdle. The cannabinoid system is expressed in the GI tract, making it a biologically plausible therapeutic target for cancers arising in these tissues.
What This Study Doesn't Tell Us
Primarily preclinical evidence. Translation from lab to clinic faces bioavailability, dosing, and regulatory challenges. CBD's GI side effects could complicate treatment of GI cancers specifically.
Questions This Raises
- ?Would oral CBD achieve sufficient concentrations at GI tumor sites?
- ?Could CBD's GI side effects be leveraged therapeutically rather than being a limitation?
Trust & Context
- Key Stat:
- CBD targeted multiple resistance mechanisms in GI cancer models
- Evidence Grade:
- Systematic review of predominantly preclinical work. Provides mechanistic understanding but clinical translation remains speculative.
- Study Age:
- Published in 2025.
- Original Title:
- Targeting Gastrointestinal Cancers with Cannabidiol: Mechanisms, Challenges, and Therapeutic Implications.
- Published In:
- Medical oncology (Northwood, London, England), 42(7), 237 (2025)
- Authors:
- Esmaeli, Mojtaba(4), Dehghanpour Dehabadi, Maryam(4)
- Database ID:
- RTHC-06416
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Could CBD help treat stomach or colon cancer?
Preclinical studies show CBD can kill GI cancer cells and may enhance chemotherapy. However, clinical evidence is lacking, and significant challenges remain in translating lab findings to patient treatment.
How does CBD fight GI cancers?
CBD was found to induce cancer cell death, stop cell division, inhibit blood vessel growth that feeds tumors, reduce inflammation, and potentially make cancer cells more sensitive to existing treatments.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06416APA
Esmaeli, Mojtaba; Dehghanpour Dehabadi, Maryam. (2025). Targeting Gastrointestinal Cancers with Cannabidiol: Mechanisms, Challenges, and Therapeutic Implications.. Medical oncology (Northwood, London, England), 42(7), 237. https://doi.org/10.1007/s12032-025-02790-6
MLA
Esmaeli, Mojtaba, et al. "Targeting Gastrointestinal Cancers with Cannabidiol: Mechanisms, Challenges, and Therapeutic Implications.." Medical oncology (Northwood, 2025. https://doi.org/10.1007/s12032-025-02790-6
RethinkTHC
RethinkTHC Research Database. "Targeting Gastrointestinal Cancers with Cannabidiol: Mechani..." RTHC-06416. Retrieved from https://rethinkthc.com/research/esmaeli-2025-targeting-gastrointestinal-cancers-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.